Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B

Photodermatol Photoimmunol Photomed. 2024 May;40(3):e12965. doi: 10.1111/phpp.12965.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Humans
  • Lenalidomide* / therapeutic use
  • Male
  • Middle Aged
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / radiotherapy
  • Psoriasis* / drug therapy
  • Psoriasis* / radiotherapy
  • Thalidomide* / adverse effects
  • Thalidomide* / analogs & derivatives
  • Thalidomide* / therapeutic use
  • Ultraviolet Therapy

Substances

  • Lenalidomide
  • Thalidomide